<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2D8E82C0-85D1-4809-90FC-4716F4AF5865"><gtr:id>2D8E82C0-85D1-4809-90FC-4716F4AF5865</gtr:id><gtr:name>Institute of Food Research</gtr:name><gtr:department>Contracts</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D8E82C0-85D1-4809-90FC-4716F4AF5865"><gtr:id>2D8E82C0-85D1-4809-90FC-4716F4AF5865</gtr:id><gtr:name>Institute of Food Research</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/20F1B153-1155-46E6-A23B-13BFF9A588C9"><gtr:id>20F1B153-1155-46E6-A23B-13BFF9A588C9</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Antony</gtr:otherNames><gtr:surname>Kroon</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FF%2F00043368"><gtr:id>767CCFE8-F0C6-44AF-B3F0-6D2017FE28D3</gtr:id><gtr:title>Influence of Flavonoid Structure and Metabolism on Cardiovascular Protection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/F/00043368</gtr:grantReference><gtr:abstractText>The proposed research will further explore the hypothesis that dietary flavonoids can protect against cardiovascular disease.
Available data suggest that dietary flavonoids can reduce the development of atherosclerosis in animals, improve endothelial function in humans, and reduce the risk of cardiovascular disease in populations. There are many hundreds of flavonoids present in the human diet, but cardiovascular benefits may be limited to a smaller number of compounds. The importance of flavonoid structure for bioactivity needs further study. Furthermore, most flavonoids undergo extensive and often rapid metabolism prior to absorption and excretion. Many previous in vitro studies have failed to take this into account and have only studied the parent aglycone form of the flavonoid. Metabolic changes to flavonoid structure could have a profound effect on their bioactivity. 

Our overall aim is to investigate the effects of individual flavonoids and their metabolites on bioactivity relevant to cardiovascular disease. The specific aims are:
AIM 1- To examine the in vitro effects of isolated flavonoids and their metabolites on markers of endothelial cell function, platelet function and inflammatory mediators produced by neutrophils and monocytes.
AIM 2- To investigate the effects of acute and regular ingestion of isolated flavonoids on brachial artery vasodilator function, and markers of endothelial cell function, platelet function and inflammation. Effects on established risk factors for cardiovascular disease will also be assessed.

The project is a collaboration between the Institute of Food Research (Norwich, UK) and the University of Western Australia (Perth, Australia).</gtr:abstractText><gtr:fund><gtr:end>2010-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-01-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>83800</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our finding that specific polyphenols inhibit VEGF signalling at very low concentrations has led to further research focussed on understanding how they do this and what useful applications they might have. Specifically, funding from the EU has been obtained to extend the number of polyphenols tested and determine the effects of human metabolism (BBS/E/F/00042625), from BBSRC and EU to investigate the mechanism (BBS/E/F00044434; BBS/E/F/00042625) and from the EU to test efficacy in vivo.

Our findings have also been used by an SME who has protected our IP via a patent and is looking to develop polyphenol products that target pathologies that involve VEGF-dependent pathological angiogenesis.</gtr:description><gtr:firstYearOfImpact>2012</gtr:firstYearOfImpact><gtr:id>F36183D0-A755-4C4A-A57E-2222EA0082C3</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>5464aa47a828b7.75634884</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>1. We have shown that the metabolites present in blood after consuming a flavonoid-rich food such as onions are able to increase the production of factors that promote relaxation of blood vessels, particularly via increases in cyclic GMP which works to relax smooth muscles and drives decreases in blood pressure.

2. We have identified three flavonoids from &amp;gt;20 that we studies that potently inhibit an important signalling pathway in vascular endothelial cells. The vascular endothelial growth factor controls the development of new blood vessels from pre-existing ones , but excessive levels of VEGF in adults and disease states such as diabetes drives atherosclerosis and increases the risk of heart disease. Our research provides evidence that particular polyphenols from tea, chocolate and apples have the potential to dampen VEGF signalling.

3. We synthesised a range of human metabolites of flavonoids. These compounds cannot currently be purchased and so we have created a unique resource for future research in this field.</gtr:description><gtr:exploitationPathways>Our research showing that metabolites of quercetin from onions are able to beneficially affect endothelial function in an in vitro model could be used to support future health claims for quercetin in relation to improving endothelial function and reducing blood pressure. It has also provided the state-of-the-art in the way that future R&amp;amp;D should investigate the potential health benefits, that is by assessing real human metabolites and not the polyphenols in foods which are different structures.

The finding that specific polyphenols can inhibit VEGF signalling has already been picked up by a company who have protected the IP and are pursuing applications in the nutraceuticals/functional foods, human health and animal health sectors.

The unique polyphenol metabolite library we have developed is and is expected to continue to be a resource used by us and other researchers interested in the health benefits of dietary polyphenols. We provide researchers with samples upon request.</gtr:exploitationPathways><gtr:id>D0E82954-B051-4C3C-B1C5-8D871A30852B</gtr:id><gtr:outcomeId>546495941eb7d1.60804843</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B996C6AA-CE46-489C-8E98-21F912D17F0F</gtr:id><gtr:title>Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta.</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/695189584e86a5efe211dd7392d7e30a"><gtr:id>695189584e86a5efe211dd7392d7e30a</gtr:id><gtr:otherNames>Lodi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9150</gtr:issn><gtr:outcomeId>5459f8b0e30892.07018074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE620FCA-B444-4DAC-9318-EDBB6EF65E79</gtr:id><gtr:title>Impact of dietary polyphenols on human platelet function--a critical review of controlled dietary intervention studies.</gtr:title><gtr:parentPublicationTitle>Molecular nutrition &amp; food research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6200262516fc79e127973f3db5b7f428"><gtr:id>6200262516fc79e127973f3db5b7f428</gtr:id><gtr:otherNames>Ostertag LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1613-4125</gtr:issn><gtr:outcomeId>5459f46833cef7.25820497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62BDF7D2-99E3-48CA-9CE4-743B294D9DC4</gtr:id><gtr:title>Fluorescence spectroscopic evaluation of the interactions of quercetin, isorhamnetin, and quercetin-3'-sulfate with different albumins</gtr:title><gtr:parentPublicationTitle>Journal of Luminescence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8899e4238d1edf7480244f84a559605"><gtr:id>e8899e4238d1edf7480244f84a559605</gtr:id><gtr:otherNames>Po?r M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-2313</gtr:issn><gtr:outcomeId>5aa910aaea8b87.03979275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>930A4A7E-F919-409C-9191-A54329349DC4</gtr:id><gtr:title>Human quercetin conjugated metabolites attenuate TNF-a-induced changes in vasomodulatory molecules in an HUASMCs/HUVECs co-culture model.</gtr:title><gtr:parentPublicationTitle>Planta medica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/695189584e86a5efe211dd7392d7e30a"><gtr:id>695189584e86a5efe211dd7392d7e30a</gtr:id><gtr:otherNames>Lodi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0032-0943</gtr:issn><gtr:outcomeId>5459f8afe09e85.33250476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>629B639F-0109-460C-AA82-C8C0906B3D19</gtr:id><gtr:title>Interaction of quercetin and its metabolites with warfarin: Displacement of warfarin from serum albumin and inhibition of CYP2C9 enzyme.</gtr:title><gtr:parentPublicationTitle>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8899e4238d1edf7480244f84a559605"><gtr:id>e8899e4238d1edf7480244f84a559605</gtr:id><gtr:otherNames>Po?r M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0753-3322</gtr:issn><gtr:outcomeId>5aa910abb36072.03685892</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F71FBE2-223D-46D8-AB3C-3990C77FAAFC</gtr:id><gtr:title>Different antitumor effects of quercetin, quercetin-3'-sulfate and quercetin-3-glucuronide in human breast cancer MCF-7 cells.</gtr:title><gtr:parentPublicationTitle>Food &amp; function</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6851393d9a7ae503884c3ce687414648"><gtr:id>6851393d9a7ae503884c3ce687414648</gtr:id><gtr:otherNames>Wu Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2042-6496</gtr:issn><gtr:outcomeId>5aa91137c6daf9.14037576</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/F/00043368</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>